Director of the National Institutes of Health says that capping research journals’ open-access fees will help rein in the $19 ...

From Day One of his second term, Trump has made cutting costs by dismantling federal entities and their staffs a top priority ...

Institutions like OMRF have had almost unbroken bipartisan support as a national biomedical research policy. Breaking it ...

An ongoing Phase III clinical trial of DengiAll, a one-shot dengue vaccine developed by Panacea Biotec, is progressing in ...

Phase-III trial of indigenous one-shot dengue vaccine by Panacea Biotec shows promising results in India, aiming for ...

Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed ...

A workshop on climate change and gender, supported by NIH (Grant no. 1R25TW010305), NCE was organised by the Centre for ...

Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed dengue vaccine, DengiAll, is likely to be completed by October across 20 ...

Two Oshkosh Northwestern readers criticize U.S. Rep. Glenn Grothman's stance on budget cuts and impeachment proceedings. One ...

Public trust in scientific integrity is eroded by the politicisation of institutions under Donald Trump's US presidency. The implications extend far beyond American borders, striking at the core of ...

Kennedy Jr. and the Make America Healthy Again movement marched through that rift as they rose to power. As secretary of ...